256 related articles for article (PubMed ID: 34791573)
81. Primary Cutaneous Anaplastic Large Cell Lymphoma-A Review of Clinical, Morphological, Immunohistochemical, and Molecular Features.
Ortiz-Hidalgo C; Pina-Oviedo S
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627126
[TBL] [Abstract][Full Text] [Related]
82. A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation.
Gru AA; Voorhess PJ
Am J Dermatopathol; 2018 Jul; 40(7):519-522. PubMed ID: 29905579
[TBL] [Abstract][Full Text] [Related]
83. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma.
Liu C; Iqbal J; Teruya-Feldstein J; Shen Y; Dabrowska MJ; Dybkaer K; Lim MS; Piva R; Barreca A; Pellegrino E; Spaccarotella E; Lachel CM; Kucuk C; Jiang CS; Hu X; Bhagavathi S; Greiner TC; Weisenburger DD; Aoun P; Perkins SL; McKeithan TW; Inghirami G; Chan WC
Blood; 2013 Sep; 122(12):2083-92. PubMed ID: 23801630
[TBL] [Abstract][Full Text] [Related]
84. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.
Cataldo KA; Jalal SM; Law ME; Ansell SM; Inwards DJ; Fine M; Arber DA; Pulford KA; Strickler JG
Am J Surg Pathol; 1999 Nov; 23(11):1386-92. PubMed ID: 10555007
[TBL] [Abstract][Full Text] [Related]
85. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
Oregel KZ; Everett E; Zhang X; Nagaraj G
Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
[TBL] [Abstract][Full Text] [Related]
86. ALK-positive anaplastic large cell lymphoma with an unusual alveolar growth pattern.
Yu G; Gao Z; Huang X
Int J Clin Exp Pathol; 2014; 7(12):9086-9. PubMed ID: 25674293
[TBL] [Abstract][Full Text] [Related]
87. Clinical presentation of anaplastic large-cell lymphoma in the central nervous system.
Nomura M; Narita Y; Miyakita Y; Ohno M; Fukushima S; Maruyama T; Muragaki Y; Shibui S
Mol Clin Oncol; 2013 Jul; 1(4):655-660. PubMed ID: 24649224
[TBL] [Abstract][Full Text] [Related]
88. The t(2;5) in human lymphomas.
Kadin ME; Morris SW
Leuk Lymphoma; 1998 Apr; 29(3-4):249-56. PubMed ID: 9684923
[TBL] [Abstract][Full Text] [Related]
89. Primary central nervous system ALK-negative anaplastic large cell lymphoma: a case report and literature review.
Yuan C; Duan H; Wang Y; Zhang J; Ou J; Wang W; Zhang M
Ann Palliat Med; 2022 Apr; 11(4):1554-1560. PubMed ID: 34263607
[TBL] [Abstract][Full Text] [Related]
90. Anaplastic large cell lymphoma, ALK-positive.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
[TBL] [Abstract][Full Text] [Related]
91. A Rare Case of Monomorphic T-Cell Posttransplant Lymphoproliferative Disorder Presenting as Primary Cutaneous Anaplastic Large Cell Lymphoma, ALK Negative.
Robbins QC; Schmieg J; Rush WL; Allbritton JI
Am J Dermatopathol; 2022 Nov; 44(11):e124-e126. PubMed ID: 36066124
[TBL] [Abstract][Full Text] [Related]
92. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.
Pham-Ledard A; Prochazkova-Carlotti M; Laharanne E; Vergier B; Jouary T; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 Mar; 130(3):816-25. PubMed ID: 19812605
[TBL] [Abstract][Full Text] [Related]
93. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma.
Agnelli L; Mereu E; Pellegrino E; Limongi T; Kwee I; Bergaggio E; Ponzoni M; Zamò A; Iqbal J; Piccaluga PP; Neri A; Chan WC; Pileri S; Bertoni F; Inghirami G; Piva R;
Blood; 2012 Aug; 120(6):1274-81. PubMed ID: 22740451
[TBL] [Abstract][Full Text] [Related]
94. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
[TBL] [Abstract][Full Text] [Related]
95. Lymphohistiocytic anaplastic large cell lymphoma involving skin: a diagnostic challenge.
Chuang SS; Hsieh YC; Ye H; Hwang WS
Pathol Res Pract; 2009; 205(4):283-7. PubMed ID: 19091487
[TBL] [Abstract][Full Text] [Related]
96. Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.
Boi M; Zucca E; Inghirami G; Bertoni F
Br J Haematol; 2015 Mar; 168(6):771-83. PubMed ID: 25559471
[TBL] [Abstract][Full Text] [Related]
97. Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.
Merkel O; Hamacher F; Griessl R; Grabner L; Schiefer AI; Prutsch N; Baer C; Egger G; Schlederer M; Krenn PW; Hartmann TN; Simonitsch-Klupp I; Plass C; Staber PB; Moriggl R; Turner SD; Greil R; Kenner L
J Pathol; 2015 Aug; 236(4):445-56. PubMed ID: 25820993
[TBL] [Abstract][Full Text] [Related]
98. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
Shin HJ; Thorson P; Gu J; Katz RL
Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
[TBL] [Abstract][Full Text] [Related]
99. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
[TBL] [Abstract][Full Text] [Related]
100. Primary central nervous system ALK positive anaplastic large cell lymphoma with predominantly leptomeningeal involvement in an adult.
Park JS; Park H; Park S; Kim SJ; Seol HJ; Ko YH
Yonsei Med J; 2013 May; 54(3):791-6. PubMed ID: 23549832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
